{
  "ptid_time": "051_S_5005_2012-11-06",
  "img_path": "/data/qiuhui/data/adni/images/051_S_5005/2012-11-06/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 98,633 mm³, 156.1% above the reference mean. With a Z-score of 3.74 (100.0th percentile), this represents profound enlargement; hippocampal volume measures 5,884 mm³, 22.2% below the reference mean. With a Z-score of -2.16 (1.5th percentile), this represents significant atrophy; whole brain volume measures 947,237 mm³, 12.2% below the reference mean. With a Z-score of -1.59 (5.6th percentile), this represents moderate atrophy. ",
  "text_data": "Age is 78.1 years. Gender is Male. Education: 14 years. Handedness: Right. Race: Black or African American. Medical history: Cardiovascular; Gastrointestinal; Renal-Genitourinary; Major Surgical Procedures. MMSE: 21.0. MoCA: 13.0. Logical Memory: 2.0. APOEε4 alleles: 2.0. Biomarker levels: Florbetapir (AV45): 1.34 SUVR (significant elevated); Amyloid beta: 318.10 pg/mL (moderate reduced); Total tau: 247.40 pg/mL (normal ); Phosphorylated tau: 25.69 pg/mL (normal ). ",
  "true_diagnosis": "Diagnosis: AD.",
  "gpt_diagnosis": "**Reasoning:** The data shows profound ventricular enlargement, significant hippocampal atrophy, and moderate whole-brain atrophy, consistent with advanced neurodegeneration. The cognitive scores (MMSE 21, MoCA 13) indicate substantial impairment, and the elevated AV45 (amyloid PET) with moderately reduced Aβ (CSF) suggests amyloid pathology, supporting Alzheimer's disease.  \n\n**Diagnosis:** **Dementia** (likely Alzheimer’s disease)  \n**Confidence:** **High**",
  "timestamp": "2025-07-26T07:38:04.692995"
}